ATE269082T1 - Polymorphe des n-methyl-n-(3-(2-thienylcarbonyl)- pyrazol(1,5-a)pyrimidin-7-yl phenyl)acetamid und zusammenstellungen und diesbezügliche methoden - Google Patents

Polymorphe des n-methyl-n-(3-(2-thienylcarbonyl)- pyrazol(1,5-a)pyrimidin-7-yl phenyl)acetamid und zusammenstellungen und diesbezügliche methoden

Info

Publication number
ATE269082T1
ATE269082T1 AT00957941T AT00957941T ATE269082T1 AT E269082 T1 ATE269082 T1 AT E269082T1 AT 00957941 T AT00957941 T AT 00957941T AT 00957941 T AT00957941 T AT 00957941T AT E269082 T1 ATE269082 T1 AT E269082T1
Authority
AT
Austria
Prior art keywords
thienylcarbonyl
polymorphs
pyrazole
acetamide
pyrimidine
Prior art date
Application number
AT00957941T
Other languages
English (en)
Inventor
William J Thiele
Patrick B O'donnell
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Application granted granted Critical
Publication of ATE269082T1 publication Critical patent/ATE269082T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT00957941T 1999-09-02 2000-09-01 Polymorphe des n-methyl-n-(3-(2-thienylcarbonyl)- pyrazol(1,5-a)pyrimidin-7-yl phenyl)acetamid und zusammenstellungen und diesbezügliche methoden ATE269082T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38952499A 1999-09-02 1999-09-02
US42162099A 1999-10-19 1999-10-19
PCT/US2000/024051 WO2001015700A1 (en) 1999-09-02 2000-09-01 POLYMORPHS OF N-METHYL-N-(3-{3-[2-THIENYLCARBONYL]-PYRAZOL-[1,5-α]-PYRIMIDIN -7-YL }PHENYL )ACETAMIDE AND COMPOSITIONS AND METHODS RELATED THERETO

Publications (1)

Publication Number Publication Date
ATE269082T1 true ATE269082T1 (de) 2004-07-15

Family

ID=27012737

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00957941T ATE269082T1 (de) 1999-09-02 2000-09-01 Polymorphe des n-methyl-n-(3-(2-thienylcarbonyl)- pyrazol(1,5-a)pyrimidin-7-yl phenyl)acetamid und zusammenstellungen und diesbezügliche methoden

Country Status (26)

Country Link
EP (2) EP1214075B1 (de)
JP (1) JP4592241B2 (de)
KR (1) KR20020035585A (de)
CN (2) CN1331865C (de)
AP (1) AP1631A (de)
AT (1) ATE269082T1 (de)
AU (2) AU769856B2 (de)
BR (1) BR0014459A (de)
CA (1) CA2382588C (de)
CZ (1) CZ2002783A3 (de)
DE (1) DE60011638T2 (de)
DK (1) DK1214075T3 (de)
EA (1) EA004706B1 (de)
ES (1) ES2222920T3 (de)
HK (1) HK1047407B (de)
HU (1) HUP0202698A3 (de)
IL (2) IL148242A0 (de)
MX (1) MXPA02002314A (de)
NO (1) NO322752B1 (de)
NZ (1) NZ517298A (de)
OA (1) OA12200A (de)
PL (1) PL353362A1 (de)
PT (1) PT1214075E (de)
SK (1) SK2782002A3 (de)
TR (1) TR200200534T2 (de)
WO (1) WO2001015700A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1532152B1 (de) * 2002-08-26 2006-10-25 Neurocrine Biosciences, Inc. Polymorph von n-methyl-n-(3- 3-¬2-thienylcarbonyl|-pyrazol-¬1,5-alpha|-pyrimidin-7-yl phenyl)acetamid und zusammensetzungen sowie verfahren hierzu
WO2004110454A1 (ja) * 2003-06-13 2004-12-23 Ishihara Sangyo Kaisha, Ltd. アデノシンＡ2ａ受容体アゴニストの投与が必要な疾患を治療又は予防するための組成物
US7371906B2 (en) 2004-08-24 2008-05-13 Eastman Kodak Company Process for photo-oxidative stability improvements
EP1918290A1 (de) * 2006-10-11 2008-05-07 Ferrer Internacional, S.A. Polymprph B von N-{2-Fluor-5-[3-(thiophen-2-carbonyl)-pyrazolo[1,5-a]pyrimidin-7-yl]phenyl}-N-methyl-acetamid
EP1956021A1 (de) * 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Verfahren zur Herstellung von Crystallin pyrazol[1,5-a]pyrimidin Verbindung
CN101177427B (zh) * 2006-11-09 2011-07-20 中国人民解放军军事医学科学院放射与辐射医学研究所 一种用于催眠的化合物的多晶型α和溶剂化物,其制备方法及含该物质的组合物
WO2010109480A2 (en) * 2009-03-24 2010-09-30 Glenmark Generics Limited Processes for the preparation of indiplon and intermediates thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ208554A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions
US4521422A (en) * 1983-06-23 1985-06-04 American Cyanamid Company Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones
US4654347A (en) * 1983-06-23 1987-03-31 American Cyanamid Company Aryl and heteroaryl[[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]methanones
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
SG30590G (en) * 1985-05-13 1995-09-18 American Cyanamid Co D7-(3-disubstituted amino) phenylaepyrazolod 1,5-aaepyrimidines
US5421422A (en) * 1993-11-19 1995-06-06 Boretec Inc Roller cutter mount for tunneling machine

Also Published As

Publication number Publication date
NO20021041L (no) 2002-04-03
CA2382588A1 (en) 2001-03-08
DK1214075T3 (da) 2004-10-25
EP1214075B1 (de) 2004-06-16
NO322752B1 (no) 2006-12-04
IL148242A0 (en) 2002-09-12
HUP0202698A3 (en) 2004-12-28
JP4592241B2 (ja) 2010-12-01
MXPA02002314A (es) 2002-08-12
CN1331865C (zh) 2007-08-15
EA200200320A1 (ru) 2002-08-29
SK2782002A3 (en) 2003-04-01
JP2003508440A (ja) 2003-03-04
OA12200A (en) 2006-05-09
DE60011638D1 (de) 2004-07-22
CZ2002783A3 (cs) 2004-01-14
ES2222920T3 (es) 2005-02-16
CN1198824C (zh) 2005-04-27
EA004706B1 (ru) 2004-06-24
NO20021041D0 (no) 2002-03-01
HK1047407B (en) 2004-12-24
PL353362A1 (en) 2003-11-17
EP1477169A1 (de) 2004-11-17
DE60011638T2 (de) 2004-10-21
AU2004201356A1 (en) 2004-04-29
AP1631A (en) 2006-07-12
HK1047407A1 (en) 2003-02-21
WO2001015700A9 (en) 2002-09-12
PT1214075E (pt) 2004-11-30
BR0014459A (pt) 2002-07-16
IL148242A (en) 2006-12-10
KR20020035585A (ko) 2002-05-11
EP1214075A4 (de) 2003-05-02
CN1680376A (zh) 2005-10-12
EP1214075A1 (de) 2002-06-19
AU6949100A (en) 2001-03-26
WO2001015700A1 (en) 2001-03-08
NZ517298A (en) 2004-01-30
AP2002002428A0 (en) 2002-03-31
CA2382588C (en) 2008-11-25
TR200200534T2 (tr) 2002-06-21
CN1374866A (zh) 2002-10-16
HUP0202698A2 (hu) 2002-12-28
AU769856B2 (en) 2004-02-05

Similar Documents

Publication Publication Date Title
ATE227290T1 (de) Verbesserung bei der herstellung von n-(3-(3- cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-n- ethyl-acetamide
DE60007257D1 (de) Verfahren zur Herstellung von Cucurbituril Derivaten
DE60120685D1 (de) Verfahren zur herstellung von dihydroxyestern und ihren derivaten
NO20050615L (no) NY POLYMORF AV N-METYL-N-(3-{3-[2-TIENYLKARBONYL]-PYRAZOL-[1,5-alfa]-PYRIMIDIN-7-YL}FENYL)ACETAMID OG PREPARAT OG ANVENDELSER RELATERT DERTIL
DE60100621D1 (de) 4-heteroaryl-1,4-diazabicyclo 3.2.2.]nonane, ihre herstellung und ihre therapeutische anwendung
ID29790A (id) PENGGUNAAN IMIDAZO(1,5-a)-PIRIDO(3,2-e)-PIRAZINON SEBAGAI OBAT
IL160076A0 (en) Process for purifying n-[3-(3-cyanopyrazolo{1,5-a} pyrimidin-7-yl) phenyl]-n-ethylacetamide (zaleplon) and crystalline forms of zaleplon accessible with the process
ATE269082T1 (de) Polymorphe des n-methyl-n-(3-(2-thienylcarbonyl)- pyrazol(1,5-a)pyrimidin-7-yl phenyl)acetamid und zusammenstellungen und diesbezügliche methoden
DE60009804D1 (de) Heteroaryl-substituierte Pyrrole, Verfahren zu ihrer Herstellung und ihre therapeutische Anwendung
PL372942A1 (en) Process for the production of n-[3-(3-cyanopyrazolo[1,5-a] pyrimidin-7-yl)phenyl]-n-ethylacetamide (zaleplon)
TWI340140B (en) N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides and compositions and methods related thereto
DE60120787D1 (de) Kombiniertes wirbelbett- und kohlenstaubverbrennungsverfahren
DE60201007D1 (de) Synthese zur herstellung von 1,4-diketopyrrolo[3,4-c]pyrrolen
ATE516267T1 (de) Vefahren zur herstellung von lactamen
NO20014781D0 (no) Fremgangsmåte ved fremstilling av trisykliske aminoalkoholderivater gjennom azider
MXPA03001048A (es) Polimorfos de zaleplon y metodos para la preparacion de los mismos.
NO20024503L (no) FremgangsmÕte for tilveiebringelse av startkulturer med en konsistent kvalitet
ATE286899T1 (de) Verfahren zur herstellung von 3- pyridylsulphonylpyrazolo(4,3-d)pyrimidin-7-one und zwischenprodukte
EE200000619A (et) Oktahüdro-6,10-diokso-6H-püridasino[1,2-a][1,2]diasepiin-1-karboksüülhappe derivaadid, nende ratseemiline segu, valmistamismeetod ja kasutamine ning vaheühendid
EE200200410A (et) Meetod atsetüülamidiniofenüülalanüültsükloheksüülglütsüülpüridinioalaniinamiidide valmistamiseks ning selleks vajalikud lähte- ja vaheühendid
DE60208551D1 (de) Verfahren zur herstellung von racemischen und enantiomerenreinen derivaten von 1,5-diaryl-3-trifluormethyl-delta2-pyrazolinen
DE60010147D1 (de) Verfahren zur Herstellung von organischen Aziden
DE50111837D1 (de) Vefahren und Bausatzgruppe für die Herstellung von Kippbrücken
DE60111327D1 (de) Olefinierungsverfahren zur Herstellung Itaconsäure- und Bernsteinsäurederivaten
NO20042542L (no) Anvendelse av ascomycin for behandling av blefarit

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1214075

Country of ref document: EP